IS7844A - Kristallskennd fumarat sölt af 1-asabísýkló[2.2.2]okt setnu fúró[2,3-c]pýridínýl karboxamíði og samsetningar og framleiðsla þeirra - Google Patents
Kristallskennd fumarat sölt af 1-asabísýkló[2.2.2]okt setnu fúró[2,3-c]pýridínýl karboxamíði og samsetningar og framleiðsla þeirraInfo
- Publication number
- IS7844A IS7844A IS7844A IS7844A IS7844A IS 7844 A IS7844 A IS 7844A IS 7844 A IS7844 A IS 7844A IS 7844 A IS7844 A IS 7844A IS 7844 A IS7844 A IS 7844A
- Authority
- IS
- Iceland
- Prior art keywords
- azabicyclo
- preparations
- formulations
- fumarate salts
- crystalline fumarate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43161902P | 2002-12-06 | 2002-12-06 | |
| PCT/IB2003/005607 WO2004052894A1 (en) | 2002-12-06 | 2003-12-01 | Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7844A true IS7844A (is) | 2005-05-12 |
Family
ID=32507764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7844A IS7844A (is) | 2002-12-06 | 2005-05-12 | Kristallskennd fumarat sölt af 1-asabísýkló[2.2.2]okt setnu fúró[2,3-c]pýridínýl karboxamíði og samsetningar og framleiðsla þeirra |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20050165047A1 (is) |
| EP (1) | EP1572700A1 (is) |
| JP (1) | JP2006510664A (is) |
| KR (1) | KR20050087826A (is) |
| CN (1) | CN1720248A (is) |
| AR (1) | AR042295A1 (is) |
| AU (1) | AU2003302911A1 (is) |
| BR (1) | BR0317019A (is) |
| CA (1) | CA2506529A1 (is) |
| CR (1) | CR7859A (is) |
| EA (1) | EA200500738A1 (is) |
| EC (1) | ECSP055834A (is) |
| HR (1) | HRP20050494A2 (is) |
| IS (1) | IS7844A (is) |
| MA (1) | MA27604A1 (is) |
| MX (1) | MXPA05005943A (is) |
| NO (1) | NO20052560L (is) |
| OA (1) | OA12968A (is) |
| PL (1) | PL377052A1 (is) |
| TW (1) | TW200427691A (is) |
| WO (1) | WO2004052894A1 (is) |
| ZA (1) | ZA200503988B (is) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6670178B1 (en) | 1992-07-10 | 2003-12-30 | Transkaryotic Therapies, Inc. | In Vivo production and delivery of insulinotropin for gene therapy |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| US7094572B2 (en) | 2003-03-14 | 2006-08-22 | Bristol-Myers Squibb | Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 |
| US8383657B2 (en) | 2007-12-21 | 2013-02-26 | Abbott Laboratories | Thiazolylidine urea and amide derivatives and methods of use thereof |
| MX2010008875A (es) * | 2008-02-13 | 2010-08-31 | Targacept Inc | Agonistas nicotinicos alfa 7 y antipsicoticos. |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| PT3029039T (pt) | 2010-05-17 | 2017-11-28 | Forum Pharmaceuticals Inc | Formulações farmacêuticas que compreendem formas cristalinas de cloridrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida mono-hidratado |
| CA2872005A1 (en) | 2012-05-08 | 2013-11-14 | Forum Pharmaceuticals, Inc. | Methods of maintaining, treating or improving cognitive function |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0285671B1 (en) * | 1986-10-13 | 2003-09-03 | Asahi Kasei Kabushiki Kaisha | Pyridine derivatives |
| AR036040A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
-
2003
- 2003-12-01 AU AU2003302911A patent/AU2003302911A1/en not_active Abandoned
- 2003-12-01 CA CA002506529A patent/CA2506529A1/en not_active Abandoned
- 2003-12-01 JP JP2004558940A patent/JP2006510664A/ja active Pending
- 2003-12-01 EP EP03812627A patent/EP1572700A1/en not_active Withdrawn
- 2003-12-01 WO PCT/IB2003/005607 patent/WO2004052894A1/en not_active Application Discontinuation
- 2003-12-01 EA EA200500738A patent/EA200500738A1/ru unknown
- 2003-12-01 MX MXPA05005943A patent/MXPA05005943A/es not_active Application Discontinuation
- 2003-12-01 OA OA1200500173A patent/OA12968A/en unknown
- 2003-12-01 CN CNA200380105166XA patent/CN1720248A/zh active Pending
- 2003-12-01 PL PL377052A patent/PL377052A1/pl not_active Application Discontinuation
- 2003-12-01 BR BR0317019-5A patent/BR0317019A/pt unknown
- 2003-12-01 KR KR1020057010196A patent/KR20050087826A/ko not_active Application Discontinuation
- 2003-12-04 AR ARP030104471A patent/AR042295A1/es unknown
- 2003-12-05 TW TW092134360A patent/TW200427691A/zh unknown
-
2004
- 2004-10-08 US US10/962,071 patent/US20050165047A1/en not_active Abandoned
-
2005
- 2005-05-12 IS IS7844A patent/IS7844A/is unknown
- 2005-05-17 ZA ZA200503988A patent/ZA200503988B/en unknown
- 2005-05-26 NO NO20052560A patent/NO20052560L/no not_active Application Discontinuation
- 2005-06-02 HR HR20050494A patent/HRP20050494A2/hr not_active Application Discontinuation
- 2005-06-03 EC EC2005005834A patent/ECSP055834A/es unknown
- 2005-06-06 CR CR7859A patent/CR7859A/es not_active Application Discontinuation
- 2005-06-06 MA MA28315A patent/MA27604A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050087826A (ko) | 2005-08-31 |
| CN1720248A (zh) | 2006-01-11 |
| MXPA05005943A (es) | 2005-08-18 |
| BR0317019A (pt) | 2005-10-25 |
| CA2506529A1 (en) | 2004-06-24 |
| AU2003302911A1 (en) | 2004-06-30 |
| JP2006510664A (ja) | 2006-03-30 |
| OA12968A (en) | 2006-10-13 |
| TW200427691A (en) | 2004-12-16 |
| MA27604A1 (fr) | 2005-11-01 |
| CR7859A (es) | 2005-07-08 |
| NO20052560D0 (no) | 2005-05-26 |
| US20050165047A1 (en) | 2005-07-28 |
| NO20052560L (no) | 2005-08-17 |
| WO2004052894A1 (en) | 2004-06-24 |
| EP1572700A1 (en) | 2005-09-14 |
| HRP20050494A2 (en) | 2005-10-31 |
| PL377052A1 (pl) | 2006-01-23 |
| ZA200503988B (en) | 2006-09-27 |
| AR042295A1 (es) | 2005-06-15 |
| EA200500738A1 (ru) | 2005-12-29 |
| ECSP055834A (es) | 2005-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7844A (is) | Kristallskennd fumarat sölt af 1-asabísýkló[2.2.2]okt setnu fúró[2,3-c]pýridínýl karboxamíði og samsetningar og framleiðsla þeirra | |
| DK1513516T3 (da) | Substitueret 3-amino-thieno(2,3-b)-pyridin-2-carboxylsyreamid-forbindelser og fremgangsmåder til fremstilling og deres anvendelser | |
| MXPA03006260A (es) | Derivados de amina sustituidos y metodos de uso. | |
| DK2380568T3 (da) | Fremgangsmåde til fremstilling og krystallisation af reduceret coenzyme Q 10 | |
| HK1091207A1 (en) | Control of parasites in animals by the use of imidazo Ä1,2-BÜpyridazine derivatives | |
| MXPA03006010A (es) | Derivados de arilamina sustituida y metodos de uso. | |
| IS7913A (is) | Pýrasóló[3,4-b]pýridín efnasambönd, og notkun þeirra sem fosfórdíesterasa hindrar | |
| AU2002319249A1 (en) | Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators | |
| PL367131A1 (en) | Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators | |
| EP1501615A4 (en) | COLLAPSE ROCK AND USE METHOD THEREFOR | |
| DK1434485T3 (da) | Nicotinsyre-heterocyclyl-amider og analoge pyrimidin-derivater til anvendelse som pesticider | |
| IS6630A (is) | 5-klór-3-(4-metansúlfónýlfenýl)-6'-metýl-[2,3']bípýridinýl á hreinu kristallaformi og aðferð til smíði þess | |
| DK1537096T3 (da) | Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf | |
| ATE309247T1 (de) | Heteroaryl substituierte 2-pyridinyl und 2- pyrimidinyl-6,7,8,9-tetrahydropyrimido(1,2- a)pyrimidin-4-onderivate | |
| DK1383733T3 (da) | Fremgangsmåde til fremstilling af 1,3-substituerede indener og aryl-sammenföjede azapolycykliske forbindelser | |
| AP1848A (en) | Pyridine carboxamide derivatives and their use as pesticides | |
| DK1228028T3 (da) | Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser | |
| NO20052124D0 (no) | Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse | |
| PL374259A1 (en) | Novel heterocyclic compounds as selective bacterial dhfr inhibitors and their uses thereof | |
| DK1381382T3 (da) | Fremgangsmåder og præparater til behandling af öjensygdomme | |
| DK1472221T3 (da) | Substituerede indoler, fremgangsmåde til fremstilling deraf og deres anvendelse til bekæmpelse af smerter | |
| AU2001227114A1 (en) | Substituted cyanoacetamide derivatives and herbicides | |
| DK1353912T3 (da) | 2-Arylimino-2,3-dihydrothiazolderivater, fremgangsmåderne til deres fremstilling og deres terapeutiske anvendelse | |
| NO20024105L (no) | Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse | |
| PT1192163E (pt) | Ditiepino¬6,5-b|piridinas e composicoes e metodos relacionados |